about
Plasma sphingolipids in HIV-associated chronic obstructive pulmonary disease.Will expanded ART use reduce the burden of HIV-associated chronic lung disease?Vitamin D and responses to inhaled fluticasone in severe chronic obstructive pulmonary disease.Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control studyVitamin D status and longitudinal lung function decline in the Lung Health Study.Prevalence and correlates of obstructive sleep apnoea among patients with and without HIV infection.Self-reported alcohol intake and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study.Sleep Apnea Symptoms as a Predictor of Fatigue in an Urban HIV Clinic.Supplemental vitamin D and physical performance in COPD: a pilot randomized trial.Obstructive Lung Diseases in HIV: A Clinical Review and Identification of Key Future Research Needs.HIV antiretroviral therapy reduces circulating surfactant protein-D levels.High-dose oral N-acetylcysteine fails to improve respiratory health status in patients with chronic obstructive pulmonary disease and chronic bronchitis: a randomized, placebo-controlled trialContemporary issues in the diagnosis and treatment of obstructive sleep apnea.Vitamin D Concentrations and Obstructive Sleep Apnea in a Multicenter Cohort of Older MalesManaging stable COPD in 2009: incorporating results from recent clinical studies into a goal-directed approach for clinicians.Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responsesPulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.High-resolution wrist-worn overnight oximetry has high positive predictive value for obstructive sleep apnea in a sleep study referral population.Review: In obstructive sleep apnea, CPAP and mandibular devices do not differ for reducing blood pressure.Trajectories of Sleep Disturbance Severity in HIV-Infected and Uninfected Veterans.Sleep Disturbance Among HIV-Infected and Uninfected Veterans.Serum bilirubin and the risk of chronic obstructive pulmonary disease exacerbations.Severe vitamin D deficiency: a biomarker of exacerbation risk? : a reply to Heulens.Implantable cardioverter-defibrillators in patients with COPD.STOP-BANG questionnaire performance in a Veterans Affairs unattended sleep study program.Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.Provider Types and Outcomes in Obstructive Sleep Apnea Case Finding and Treatment: A Systematic Review.Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy.Simpson's paradox.CD5-Positive Tracheal Mucosa-associated Lymphoid Tissue Lymphoma Presenting with Prandial Dyspnea.Unauthorized Online Sales of Secondhand Continuous Positive Airway Pressure Devices.Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events: A Cohort Analysis.Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus StudyThe relationship between oral health and COPD exacerbationsPrevention of postextubation laryngeal oedemaAntibiotic prophylaxis for chronic obstructive pulmonary disease: resurrecting an old ideaExhaled nitric oxide and steroid responses in chronic obstructive pulmonary diseaseInfluenza vaccines in patients with IBD: ready for primetime?Smoking and Accelerated Lung Function Decline in HIV-Positive Individuals: A Secondary Analysis of the START Pulmonary SubstudyAssociation of sleep-disordered breathing with total healthcare costs and utilization in older men: the Outcomes of Sleep Disorders in Older Men (MrOS Sleep) study
P50
Q33552645-A3D650A7-2590-4A3A-A2A3-32F7DE0E349EQ33797611-D21936C5-B4BD-4060-B5E0-3CFCB0E38B73Q34554796-DA357C1B-8D17-405F-8E3C-DA51004DBA1AQ34606647-04DD37A9-BC5B-4364-B940-230FB55727D3Q34759932-1F0D2D07-0712-412C-AE74-FCE60391E9E6Q34989817-58E5DD45-743C-4AFF-B266-13DFEBCFDA43Q35892443-C029E0A1-485B-4B7B-96D1-D21E424AACA1Q36263591-814BB4F2-4232-4EA5-9A83-DE165928DAECQ36617689-0B5C07FB-7792-49D6-94A8-12FD3E39C5EEQ36733646-EC9AA4F9-5EDA-4575-AB28-1C5561150984Q36776685-10F084AA-1F9F-41D7-852B-AB34744A40D4Q36838747-17686F5E-7A9F-451A-9B78-BBE22D395581Q37226388-01CAE39E-0CBD-46DD-8522-FCA822181938Q37247926-D539244B-D274-447E-B2F8-6374CBFC0809Q37380512-71835A9D-BB2B-435E-8ABB-EAFC412C4622Q37416103-18D8FAC8-5137-46DD-9BAF-42FAFD325A2EQ37613840-3DCC992A-1E82-4F7E-B814-3B1E81EA9D27Q38583708-1FE00A9C-B380-497C-94E3-47A3AFA76C27Q38773908-A449221B-EE59-460E-AE33-E3F7F0502A57Q40260140-01EB6845-9DF8-4A93-A509-BE7CB8BA3DE9Q40427690-21887967-AA26-488D-9ED1-F6C3987EB112Q42633506-3241C145-8D8A-4DF1-B046-98C380993B35Q43249067-9655B841-64AB-4550-A0F3-DBF8515AA7E5Q44884290-073DA01D-544C-461F-A54F-085961B11E60Q45329146-79F9BED2-5CB9-4FD4-95D6-989C1571CC05Q46174569-EE14EEA8-4F5D-40A3-8A92-6A4830E12090Q47639557-2A537F35-644D-4B6A-9894-F85693B949CBQ47693953-FCCD5A37-AE5D-4257-ABAD-E4003503BD62Q47767407-27034A03-5648-4479-8C56-253FA96ED4C8Q47809241-583F702E-0ACC-4835-8635-B8698D74F16AQ47825446-8D9E5F4C-E5EE-4C1D-9B47-33D0B8C2D49DQ50015160-461A7EF5-414E-4B27-A47B-959DC1B74472Q59298018-798A3F0E-6CD4-4ACC-8883-15FC14DA5BE5Q64097084-90EB7A15-9DD6-4FCB-A692-E227178A7E4BQ80581165-C5AB8136-D05F-489F-9499-706022A536D6Q82677980-3EA927C8-527E-4866-BBCB-08AC99E07278Q83039363-495E07F9-A310-4A07-8CA0-DA61A713EAC3Q83305350-7C2EF3A9-41ED-48A0-A765-79DC8C52F278Q89474433-456F943B-0F4F-4554-A90B-D3F9DDFEEC78Q90273844-F11096A5-09FD-4F84-AC55-8383EB2BA405
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ken M Kunisaki
@nl
Ken M Kunisaki
@sl
Ken M. Kunisaki
@en
Ken M. Kunisaki
@es
type
label
Ken M Kunisaki
@nl
Ken M Kunisaki
@sl
Ken M. Kunisaki
@en
Ken M. Kunisaki
@es
prefLabel
Ken M Kunisaki
@nl
Ken M Kunisaki
@sl
Ken M. Kunisaki
@en
Ken M. Kunisaki
@es
P106
P1153
16233346800
P21
P31
P3835
ken-kunisaki
P496
0000-0001-8644-2827